Replies to post #16534 on Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

Either way.... is next Tuesday Feb 7th.

We are now overDEW -

Jan. 6 - Momenta Provides Year-End 2016 Corporate Update

....a final approval could be granted following the expiration of COPAXONE 40 mg regulatory exclusivity on January 28, 2017.

http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=1006859

[alternatepatel]

how do you derive Feb 7th?

Teva received DRL's First Notice Letter on or about August 6, 2014.
link

30 month stay shall have expired on 6th Feb 2017, right?

Ok here it is:

source 1

source 2